Century Therapeutics
IPSC | NASDAQ
$1.64
-$0.01 (-0.61%)
At close: Nov 16, 2026, 4:00 PM ET
$1.64
$0.00 (-0.18%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-0.61%
(1D)No price chart data available for 1D timeframe.
Rating
45.2
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #383/1021 (Top 38%)
Key Statistics
Market Data
Market Cap $338.56M
1D Range
1.57 1.71
52W Range
0.48 2.94
Valuation (TTM)
PE -2.19
PB 1.61
EV/EBITDA -2.96
Valuation (NTM)
Forward PE N/A
Forward PEG -0.01
Price Target $3.00
Cash Flow
FCF Yield -25.3%
SBC Adj. FCF Yield -27.1%
SBC Impact -7.2%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y -3.5% |
41.2%
Dil EPS 3Y | 5Y 56.3% |
32.7%
FCF 3Y | 5Y 13.3% |
-13.9%
Returns
ROA -37.6%
ROE -45.6%
ROIC -42.7%
Financial Health
Net Cash
$117.2M
Current Ratio 8.74
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Century Therapeutics, Inc. is a biotechnology company dedicated to pioneering allogeneic cell therapies for a range of cancers, specifically solid tumors and hematological malignancies. The firm's for...
Sector Healthcare
Industry Biotechnology
Employees 78
IPO Date Jun 18, 2021
Website www.centurytx.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
3
Consensus
Buy
Price Target
$3.00
Upside
+82.93%
Buy (2)
Hold (1)
Sell (0)
Add to Watchlist
Select watchlists to add or remove IPSC